|
|
|
|
||
|
||
|
Vol. 7, Nos. 1-43 pp. 1-1268 Jan. 2-Oct. 30 , 2009 A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
XARELTO
– Anticoagulant makers plan to respond to FDA, 866
– Cancer drug, generic challenged (D.N.J.), 438
– Arthritis drug, FDA panel urges approval, 1113
– Sepsis drug, FDA probes bleeding events and deaths, 160
– Asthma drug, heart attack and stroke risk examined by FDA, 860
– Asthma drug, dispute over generic settled (D. Del.), 286; generic launched, 1055
– Antihistamine maker challenges generic (E.D.N.C.), 733
– Application for generic, In Brief, 747 – Approval, In Brief, 1005 Contact the Webmaster at webmaster@bna.com Copyright © The Bureau of National Affairs, Inc. All Rights Reserved. |
